Docetaxel and Epirubicin With and Without G-CSF in Treating Women With Metastatic Breast Cancer
Clinical trial NCT00002866 · COMPLETED
Trial details
- NCT number
- NCT00002866
- Sponsor
- NCIC Clinical Trials Group
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 1996-08-12
- Primary completion
- 2005-07-19
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.